CompletedNCT05537584
Matching antidepressants to predict response to loss of pleasure
About this title
Read the official source — NCT05537584Medication studyAges 18–64United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- BelmontSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: September 30, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 57
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT05537584
- Official title
Show the full official title
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Sertraline and Bupropion.
Who was this study for?
Listed age limits: 18 years to 64 years.
